●In vitro and in vivo efficacy screening

Genevoyager provides efficacy screening services both in vitro and in vivo, covering molecular level, enzyme level, cellular level, organ and tissue level, and animal level testing, tailored to customer needs.

●Early screening based on pharmacokinetics

Genevoyager utilizes techniques such as ELISA, LC-MS, HPLC, and other technical methods to provide screening experiments for the bioavailability and metabolic characteristics of early-stage compounds.

● Early toxicity screening

Genevoyager offers various toxicity tests including general toxicity, genetic toxicity, reproductive toxicity, acute toxicity, safety pharmacology, carcinogenicity, local toxicity, cardiac toxicity, etc., to assist clients in rapidly screening compounds with lower toxicity levels.